Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 32.1B | 23.4B | 22.9B | 30.5B |
Cost of revenue | 2.9B | 5.9B | 1.0B | 3.1B |
Gross profit | 29.2B | 17.5B | 21.8B | 27.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 7.0B | -5.1B | 4.7B | 5.7B |
Operating income | 13.7B | 9.9B | 7.2B | 15.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.6B | 21.1B | 6.6B | 2.9B |
Other income expense | — | — | — | — |
Pretax income | 13.3B | 11.1B | 4.0B | 15.7B |
Tax provision | 3.9B | 2.5B | 1.0B | 6.1B |
Net income | 11.3B | 9.2B | 3.3B | 10.7B |
Basic EPS | 1.1 | — | 0.2 | 0.9 |
Diluted EPS | 1.1 | — | 0.2 | 0.9 |
Basic average shares | 10.0B | — | 10.1B | 10.1B |
Diluted average shares | 10.0B | — | 10.1B | 10.1B |
EBITDA | 20.3B | 29.7B | 13.5B | 21.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -661.4M | -659.9M | -989M | -1.6B |
Preferred stock dividends | 0 | 0 | 0 | 0 |